VANGUARD GROUP INC - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 3 filers reported holding MARKER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$470,070
-27.8%
1,767,853
+0.1%
0.00%
Q3 2022$651,000
-14.5%
1,766,291
-23.4%
0.00%
Q2 2022$761,000
-25.0%
2,307,2940.0%0.00%
Q1 2022$1,015,000
-60.3%
2,307,294
-14.2%
0.00%
Q4 2021$2,554,000
-43.8%
2,688,071
-0.1%
0.00%
Q3 2021$4,548,000
-39.4%
2,691,7100.0%0.00%
Q2 2021$7,510,000
+31.5%
2,691,710
+5.6%
0.00%
Q1 2021$5,711,000
+182.9%
2,549,485
+83.1%
0.00%
Q4 2020$2,019,000
-7.6%
1,392,188
-4.5%
0.00%
Q3 2020$2,185,000
-31.2%
1,457,369
-5.0%
0.00%
Q2 2020$3,174,000
+8.4%
1,533,516
-0.5%
0.00%
Q1 2020$2,928,000
-34.3%
1,541,534
-0.3%
0.00%
Q4 2019$4,455,000
-43.8%
1,546,806
-0.4%
0.00%
Q3 2019$7,934,000
-29.6%
1,552,620
+9.0%
0.00%
Q2 2019$11,277,000
+39.4%
1,423,870
+16.2%
0.00%
Q1 2019$8,088,000
+52.6%
1,225,403
+28.3%
0.00%
Q4 2018$5,301,000955,2370.00%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,142,857$2,986,0001.05%
ACT CAPITAL MANAGEMENT, LLC 354,400$337,0000.24%
NEA Management Company, LLC 10,714,285$10,179,0000.21%
Long Focus Capital Management, LLC 1,233,257$1,172,0000.16%
Mandatum Life Insurance Co Ltd 99,000$94,0000.02%
MATRIX ASSET ADVISORS INC/NY 150,000$143,0000.02%
AR ASSET MANAGEMENT INC 71,500$68,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 590,118$561,0000.01%
WealthTrust Axiom LLC 22,700$21,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 324,216$308,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders